Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(13%)
Results Posted
50%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_1
4
50%
Ph not_applicable
1
13%
Ph early_phase_1
1
13%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 14 (50.0%)
Phase 22 (25.0%)
N/A1 (12.5%)

Trials by Status

recruiting113%
completed675%
terminated113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_1

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

NCT07407348
completedphase_2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

NCT03529773
terminatedphase_2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT03572062
completedearly_phase_1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

NCT03718390
completedphase_1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

NCT02426632
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07407348Phase 1

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

Recruiting
NCT03529773Phase 2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Completed
NCT03572062Phase 2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Terminated
NCT03718390Early Phase 1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Completed
NCT02426632Phase 1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed
NCT00848744Not Applicable

Comparison of Two Salicylic Acid Formulations

Completed
NCT00495274Phase 1

Bioequivalence and Food Effect Study in Healthy Volunteers

Completed
NCT00548769Phase 1

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Completed

All 8 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
8